ADAM VOGEL to Middle Aged
This is a "connection" page, showing publications ADAM VOGEL has written about Middle Aged.
Connection Strength
0.335
-
An open-label study of pemigatinib in cholangiocarcinoma: final results from FIGHT-202. ESMO Open. 2024 Jun; 9(6):103488.
Score: 0.053
-
Features of speech and swallowing dysfunction in pre-ataxic spinocerebellar ataxia type 2. Neurology. 2020 07 14; 95(2):e194-e205.
Score: 0.040
-
ParkinSong: Outcomes of a 12-Month Controlled Trial of Therapeutic Singing Groups in Parkinson's Disease. J Parkinsons Dis. 2020; 10(3):1217-1230.
Score: 0.039
-
Motor speech signature of behavioral variant frontotemporal dementia: Refining the phenotype. Neurology. 2017 Aug 22; 89(8):837-844.
Score: 0.033
-
Defining risk for infectious complications on extracorporeal life support. J Pediatr Surg. 2011 Dec; 46(12):2260-4.
Score: 0.022
-
Rapid repetitive syllable sounds associate with episodic memory, executive function, and working memory in cognitively healthy and subjectively impaired older adults. Geroscience. 2025 Dec; 47(6):6683-6698.
Score: 0.014
-
Understanding speech and language in KIF1A-associated neurological disorder. Eur J Hum Genet. 2026 Jan; 34(1):78-89.
Score: 0.014
-
Investigating changes in connected speech in nonfluent/agrammatic primary progressive aphasia following script training. Cortex. 2025 Feb; 183:193-210.
Score: 0.014
-
Self-Reported Stuttering Severity Is Accurate: Informing Methods for Large-Scale Data Collection in Stuttering. J Speech Lang Hear Res. 2024 Oct 24; 67(10S):4015-4024.
Score: 0.013
-
Development, feasibility testing, and preliminary evaluation of the Communication with an Artificial airway Tool (CAT): Results of the Crit-CAT pilot study. Aust Crit Care. 2024 01; 37(1):127-137.
Score: 0.013
-
Clinical characteristics and outcome of patients with combined hepatocellular-cholangiocarcinoma-a European multicenter cohort. ESMO Open. 2023 02; 8(1):100783.
Score: 0.012
-
Use of illicit amphetamines is associated with long-lasting changes in hand circuitry and control. Clin Neurophysiol. 2019 05; 130(5):655-665.
Score: 0.009
-
Coordination and timing deficits in speech and swallowing in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS). J Neurol. 2018 Sep; 265(9):2060-2070.
Score: 0.009
-
Validation and Psychometric Properties of the German Version of the SWAL-QOL. Dysphagia. 2018 08; 33(4):431-440.
Score: 0.008
-
Interferon-free therapy of chronic hepatitis C with direct-acting antivirals does not change the short-term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis. Aliment Pharmacol Ther. 2018 02; 47(4):516-525.
Score: 0.008
-
Speech and swallowing abnormalities in adults with POLG associated ataxia (POLG-A). Mitochondrion. 2017 11; 37:1-7.
Score: 0.008
-
Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study. Ann Oncol. 2016 07; 27(7):1273-9.
Score: 0.007
-
A predictive model for diagnosing stroke-related apraxia of speech. Neuropsychologia. 2016 Jan 29; 81:129-139.
Score: 0.007
-
Logopenic and nonfluent variants of primary progressive aphasia are differentiated by acoustic measures of speech production. PLoS One. 2014; 9(2):e89864.
Score: 0.006
-
Vocal acoustic biomarkers of depression severity and treatment response. Biol Psychiatry. 2012 Oct 01; 72(7):580-7.
Score: 0.006